Evidence map›Paper›PMID 23821143›Full record

ReviewSub-cellular biochemistry2013

Peroxisomes and the antiviral responses of mammalian cells.

Charlotte Odendall, Jonathan C Kagan

Abstract readReview
In one paragraph

Review in Sub-cellular biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Metabolic features of chronic fatigue syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Peroxisomes and Kidney Injury.Antioxidants & redox signaling · 2016
    Review
  9. Peroxisome-mitochondria interplay and disease.Journal of inherited metabolic disease · 2015
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Charlotte OdendallHarvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, 02115, USA.
Jonathan C Kagan
Boston Children's Hospital · USHarvard University · US

Funding

Initiation and Regulation of Antiviral Innate ImmunityR01AI093589 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2011 to 2020
$4.4M
NIAID NIH HHS R01 AI093589
6 · The paper itself

Abstract

Cell biology and microbiology are some of the oldest areas of scientific inquiry. Despite the depth of knowledge we now have in these respective fields, much remains unclear about how microorganisms interact with host intracellular organelles. Perhaps nowhere is this statement more accurate than in the role of peroxisomes in microbial infections. Peroxisomes were one of the first organelles discovered by Christian De Duve over 50 years ago (de Duve Ann N Y Acad Sci 386:1-4, 1982). These organelles are ubiquitously found in eukaryotic cells, where they serve several well-defined functions in lipid and oxygen homeostasis (Waterham and Wanders Biochim Biophys Acta 1822:1325, 2012). This chapter will discuss the emerging evidence that indicates that in addition to their functions in cellular metabolism, peroxisomes play an important role in viral infections.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsHost-Pathogen InteractionsHumansImmunity, InnateMitochondriaPeroxisomesReceptors, ImmunologicSignal TransductionVirus DiseasesAdaptor Proteins, Signal TransducingMAVS protein, humanReceptors, Immunologic

Identifiers

PMID23821143
PMCPMC3947803
OpenAlexW119894577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.